Cipla Limited (BOM:500087)
India · Delayed Price · Currency is INR 1,438.75
-2.95 (-0.20%)
At close: Jul 10, 2026
Cipla Market Cap
Cipla has a market cap or net worth of 1.16 trillion as of July 13, 2026. Its market cap has decreased by -2.99% in one year.
Market Cap
1.16T
Enterprise Value
1.07T
Revenue
278.28B
Ranking
n/a
PE Ratio
29.97
Stock Price
1,438.75
Market Cap Chart
Since May 30, 1996, Cipla's market cap has increased from 1.51B to 1.16T, an increase of 76,714.86%. That is a compound annual growth rate of 24.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 1.16T | -4.75% |
| Dec 31, 2025 | 1.22T | -1.14% |
| Dec 31, 2024 | 1.23T | 22.72% |
| Dec 29, 2023 | 1.01T | 15.86% |
| Dec 30, 2022 | 868.44B | 14.01% |
| Dec 31, 2021 | 761.69B | 15.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.66T |
| Lupin | 1.14T |
| Dr. Reddy's Laboratories | 1.04T |
| Abbott India | 576.39B |
| GlaxoSmithKline Pharmaceuticals | 412.59B |
| J. B. Chemicals & Pharmaceuticals | 391.39B |
| Rubicon Research | 235.82B |
| Granules India | 220.43B |